nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—epilepsy syndrome	0.229	1	CbGaD
Linagliptin—ABCB1—Levetiracetam—epilepsy syndrome	0.0524	0.0906	CbGbCtD
Linagliptin—ABCB1—Clobazam—epilepsy syndrome	0.0363	0.0628	CbGbCtD
Linagliptin—ABCB1—Lamotrigine—epilepsy syndrome	0.0349	0.0605	CbGbCtD
Linagliptin—ABCB1—Carbamazepine—epilepsy syndrome	0.0301	0.0521	CbGbCtD
Linagliptin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0287	0.0497	CbGbCtD
Linagliptin—ABCB1—Phenytoin—epilepsy syndrome	0.027	0.0467	CbGbCtD
Linagliptin—CYP3A4—Felbamate—epilepsy syndrome	0.0267	0.0462	CbGbCtD
Linagliptin—CYP3A4—Trimethadione—epilepsy syndrome	0.0267	0.0462	CbGbCtD
Linagliptin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0251	0.0434	CbGbCtD
Linagliptin—ABCB1—Phenobarbital—epilepsy syndrome	0.024	0.0416	CbGbCtD
Linagliptin—ABCB1—Midazolam—epilepsy syndrome	0.0237	0.041	CbGbCtD
Linagliptin—ABCB1—Diazepam—epilepsy syndrome	0.0228	0.0395	CbGbCtD
Linagliptin—CYP3A4—Clonazepam—epilepsy syndrome	0.0227	0.0393	CbGbCtD
Linagliptin—CYP3A4—Clobazam—epilepsy syndrome	0.0217	0.0376	CbGbCtD
Linagliptin—CYP3A4—Rufinamide—epilepsy syndrome	0.0185	0.032	CbGbCtD
Linagliptin—CYP3A4—Carbamazepine—epilepsy syndrome	0.018	0.0312	CbGbCtD
Linagliptin—CYP3A4—Primidone—epilepsy syndrome	0.0168	0.0291	CbGbCtD
Linagliptin—CYP3A4—Phenytoin—epilepsy syndrome	0.0162	0.028	CbGbCtD
Linagliptin—CYP3A4—Propofol—epilepsy syndrome	0.0151	0.0261	CbGbCtD
Linagliptin—CYP3A4—Acetazolamide—epilepsy syndrome	0.0144	0.0249	CbGbCtD
Linagliptin—CYP3A4—Phenobarbital—epilepsy syndrome	0.0144	0.0249	CbGbCtD
Linagliptin—CYP3A4—Midazolam—epilepsy syndrome	0.0142	0.0246	CbGbCtD
Linagliptin—CYP3A4—Diazepam—epilepsy syndrome	0.0137	0.0236	CbGbCtD
Linagliptin—CYP3A4—Zonisamide—epilepsy syndrome	0.0133	0.0231	CbGbCtD
Linagliptin—CYP3A4—Valproic Acid—epilepsy syndrome	0.0108	0.0186	CbGbCtD
Linagliptin—CYP3A4—Topiramate—epilepsy syndrome	0.00971	0.0168	CbGbCtD
Linagliptin—Alogliptin—CYP2D6—epilepsy syndrome	0.00239	1	CrCbGaD
Linagliptin—Urticaria—Acetazolamide—epilepsy syndrome	0.000344	0.00189	CcSEcCtD
Linagliptin—Myalgia—Clonazepam—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Arthralgia—Clonazepam—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Diarrhoea—Lacosamide—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Rash—Phenobarbital—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Dermatitis—Phenobarbital—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Pancreatitis—Gabapentin—epilepsy syndrome	0.000342	0.00188	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Fosphenytoin—epilepsy syndrome	0.000341	0.00188	CcSEcCtD
Linagliptin—Arthralgia—Phenytoin—epilepsy syndrome	0.00034	0.00187	CcSEcCtD
Linagliptin—Myalgia—Phenytoin—epilepsy syndrome	0.00034	0.00187	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.00034	0.00187	CcSEcCtD
Linagliptin—Headache—Phenobarbital—epilepsy syndrome	0.00034	0.00187	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000339	0.00187	CcSEcCtD
Linagliptin—Pain in extremity—Topiramate—epilepsy syndrome	0.000339	0.00186	CcSEcCtD
Linagliptin—Infestation NOS—Pregabalin—epilepsy syndrome	0.000339	0.00186	CcSEcCtD
Linagliptin—Infestation—Pregabalin—epilepsy syndrome	0.000339	0.00186	CcSEcCtD
Linagliptin—Infection—Zonisamide—epilepsy syndrome	0.000338	0.00186	CcSEcCtD
Linagliptin—Myalgia—Oxcarbazepine—epilepsy syndrome	0.000338	0.00186	CcSEcCtD
Linagliptin—Arthralgia—Oxcarbazepine—epilepsy syndrome	0.000338	0.00186	CcSEcCtD
Linagliptin—Angioedema—Lamotrigine—epilepsy syndrome	0.000337	0.00185	CcSEcCtD
Linagliptin—Constipation—Midazolam—epilepsy syndrome	0.000336	0.00185	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000336	0.00185	CcSEcCtD
Linagliptin—Rash—Rufinamide—epilepsy syndrome	0.000336	0.00185	CcSEcCtD
Linagliptin—Dermatitis—Rufinamide—epilepsy syndrome	0.000335	0.00184	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000335	0.00184	CcSEcCtD
Linagliptin—Headache—Rufinamide—epilepsy syndrome	0.000334	0.00183	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000333	0.00183	CcSEcCtD
Linagliptin—Diarrhoea—Clobazam—epilepsy syndrome	0.000332	0.00183	CcSEcCtD
Linagliptin—Constipation—Levetiracetam—epilepsy syndrome	0.000332	0.00182	CcSEcCtD
Linagliptin—Skin disorder—Zonisamide—epilepsy syndrome	0.000331	0.00182	CcSEcCtD
Linagliptin—Urinary tract infection—Pregabalin—epilepsy syndrome	0.000329	0.00181	CcSEcCtD
Linagliptin—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000328	0.0018	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000328	0.0018	CcSEcCtD
Linagliptin—Infection—Clonazepam—epilepsy syndrome	0.000326	0.00179	CcSEcCtD
Linagliptin—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000326	0.00179	CcSEcCtD
Linagliptin—Myalgia—Carbamazepine—epilepsy syndrome	0.000325	0.00178	CcSEcCtD
Linagliptin—Arthralgia—Carbamazepine—epilepsy syndrome	0.000325	0.00178	CcSEcCtD
Linagliptin—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000324	0.00178	CcSEcCtD
Linagliptin—Infection—Phenytoin—epilepsy syndrome	0.000324	0.00178	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Gabapentin—epilepsy syndrome	0.000324	0.00178	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000322	0.00177	CcSEcCtD
Linagliptin—Infection—Oxcarbazepine—epilepsy syndrome	0.000322	0.00177	CcSEcCtD
Linagliptin—Cough—Lamotrigine—epilepsy syndrome	0.000322	0.00177	CcSEcCtD
Linagliptin—Constipation—Fosphenytoin—epilepsy syndrome	0.00032	0.00176	CcSEcCtD
Linagliptin—Urticaria—Propofol—epilepsy syndrome	0.000319	0.00175	CcSEcCtD
Linagliptin—Skin disorder—Clonazepam—epilepsy syndrome	0.000319	0.00175	CcSEcCtD
Linagliptin—Weight increased—Gabapentin—epilepsy syndrome	0.000317	0.00174	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000317	0.00174	CcSEcCtD
Linagliptin—Rash—Lacosamide—epilepsy syndrome	0.000315	0.00173	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000315	0.00173	CcSEcCtD
Linagliptin—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000315	0.00173	CcSEcCtD
Linagliptin—Dermatitis—Lacosamide—epilepsy syndrome	0.000315	0.00173	CcSEcCtD
Linagliptin—Arthralgia—Lamotrigine—epilepsy syndrome	0.000314	0.00173	CcSEcCtD
Linagliptin—Myalgia—Lamotrigine—epilepsy syndrome	0.000314	0.00173	CcSEcCtD
Linagliptin—Headache—Lacosamide—epilepsy syndrome	0.000313	0.00172	CcSEcCtD
Linagliptin—Constipation—Vigabatrin—epilepsy syndrome	0.000312	0.00172	CcSEcCtD
Linagliptin—Urticaria—Midazolam—epilepsy syndrome	0.000312	0.00172	CcSEcCtD
Linagliptin—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000311	0.00171	CcSEcCtD
Linagliptin—Infestation NOS—Gabapentin—epilepsy syndrome	0.000311	0.00171	CcSEcCtD
Linagliptin—Infestation—Gabapentin—epilepsy syndrome	0.000311	0.00171	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.00031	0.00171	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.00031	0.00171	CcSEcCtD
Linagliptin—Infection—Carbamazepine—epilepsy syndrome	0.000309	0.0017	CcSEcCtD
Linagliptin—Constipation—Diazepam—epilepsy syndrome	0.000307	0.00169	CcSEcCtD
Linagliptin—Rash—Clobazam—epilepsy syndrome	0.000306	0.00168	CcSEcCtD
Linagliptin—Dermatitis—Clobazam—epilepsy syndrome	0.000306	0.00168	CcSEcCtD
Linagliptin—Headache—Clobazam—epilepsy syndrome	0.000304	0.00167	CcSEcCtD
Linagliptin—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000304	0.00167	CcSEcCtD
Linagliptin—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000303	0.00167	CcSEcCtD
Linagliptin—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000303	0.00167	CcSEcCtD
Linagliptin—Skin disorder—Carbamazepine—epilepsy syndrome	0.000302	0.00166	CcSEcCtD
Linagliptin—Urinary tract infection—Gabapentin—epilepsy syndrome	0.000302	0.00166	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000299	0.00164	CcSEcCtD
Linagliptin—Infection—Lamotrigine—epilepsy syndrome	0.000299	0.00164	CcSEcCtD
Linagliptin—Urticaria—Fosphenytoin—epilepsy syndrome	0.000298	0.00164	CcSEcCtD
Linagliptin—Constipation—Felbamate—epilepsy syndrome	0.000298	0.00164	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000297	0.00163	CcSEcCtD
Linagliptin—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000296	0.00163	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000295	0.00162	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000294	0.00162	CcSEcCtD
Linagliptin—Malnutrition—Valproic Acid—epilepsy syndrome	0.000293	0.00161	CcSEcCtD
Linagliptin—Constipation—Zonisamide—epilepsy syndrome	0.000291	0.0016	CcSEcCtD
Linagliptin—Urticaria—Vigabatrin—epilepsy syndrome	0.00029	0.00159	CcSEcCtD
Linagliptin—Hypersensitivity—Midazolam—epilepsy syndrome	0.00029	0.00159	CcSEcCtD
Linagliptin—Pancreatitis—Topiramate—epilepsy syndrome	0.000287	0.00158	CcSEcCtD
Linagliptin—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000286	0.00157	CcSEcCtD
Linagliptin—Urticaria—Diazepam—epilepsy syndrome	0.000286	0.00157	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000284	0.00156	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000283	0.00156	CcSEcCtD
Linagliptin—Back pain—Valproic Acid—epilepsy syndrome	0.000283	0.00156	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000281	0.00155	CcSEcCtD
Linagliptin—Constipation—Clonazepam—epilepsy syndrome	0.000281	0.00154	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.00028	0.00154	CcSEcCtD
Linagliptin—Constipation—Phenytoin—epilepsy syndrome	0.000279	0.00153	CcSEcCtD
Linagliptin—Constipation—Oxcarbazepine—epilepsy syndrome	0.000277	0.00152	CcSEcCtD
Linagliptin—Urticaria—Felbamate—epilepsy syndrome	0.000276	0.00152	CcSEcCtD
Linagliptin—Diarrhoea—Propofol—epilepsy syndrome	0.000275	0.00151	CcSEcCtD
Linagliptin—Immune system disorder—Pregabalin—epilepsy syndrome	0.000275	0.00151	CcSEcCtD
Linagliptin—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000274	0.00151	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000274	0.00151	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000272	0.0015	CcSEcCtD
Linagliptin—Headache—Acetazolamide—epilepsy syndrome	0.000271	0.00149	CcSEcCtD
Linagliptin—Urticaria—Zonisamide—epilepsy syndrome	0.000271	0.00149	CcSEcCtD
Linagliptin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000269	0.00148	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000269	0.00148	CcSEcCtD
Linagliptin—Angioedema—Valproic Acid—epilepsy syndrome	0.000268	0.00147	CcSEcCtD
Linagliptin—Weight increased—Topiramate—epilepsy syndrome	0.000267	0.00147	CcSEcCtD
Linagliptin—Constipation—Carbamazepine—epilepsy syndrome	0.000266	0.00146	CcSEcCtD
Linagliptin—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000266	0.00146	CcSEcCtD
Linagliptin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000265	0.00146	CcSEcCtD
Linagliptin—Malnutrition—Pregabalin—epilepsy syndrome	0.000265	0.00146	CcSEcCtD
Linagliptin—Infestation NOS—Topiramate—epilepsy syndrome	0.000261	0.00144	CcSEcCtD
Linagliptin—Infestation—Topiramate—epilepsy syndrome	0.000261	0.00144	CcSEcCtD
Linagliptin—Urticaria—Clonazepam—epilepsy syndrome	0.000261	0.00143	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00026	0.00143	CcSEcCtD
Linagliptin—Urticaria—Phenytoin—epilepsy syndrome	0.000259	0.00142	CcSEcCtD
Linagliptin—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000258	0.00142	CcSEcCtD
Linagliptin—Constipation—Lamotrigine—epilepsy syndrome	0.000257	0.00141	CcSEcCtD
Linagliptin—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000256	0.00141	CcSEcCtD
Linagliptin—Back pain—Pregabalin—epilepsy syndrome	0.000256	0.00141	CcSEcCtD
Linagliptin—Cough—Valproic Acid—epilepsy syndrome	0.000256	0.0014	CcSEcCtD
Linagliptin—Urinary tract infection—Topiramate—epilepsy syndrome	0.000254	0.0014	CcSEcCtD
Linagliptin—Rash—Propofol—epilepsy syndrome	0.000253	0.00139	CcSEcCtD
Linagliptin—Dermatitis—Propofol—epilepsy syndrome	0.000253	0.00139	CcSEcCtD
Linagliptin—Immune system disorder—Gabapentin—epilepsy syndrome	0.000252	0.00138	CcSEcCtD
Linagliptin—Headache—Propofol—epilepsy syndrome	0.000252	0.00138	CcSEcCtD
Linagliptin—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000251	0.00138	CcSEcCtD
Linagliptin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000251	0.00138	CcSEcCtD
Linagliptin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00025	0.00137	CcSEcCtD
Linagliptin—Arthralgia—Valproic Acid—epilepsy syndrome	0.000249	0.00137	CcSEcCtD
Linagliptin—Myalgia—Valproic Acid—epilepsy syndrome	0.000249	0.00137	CcSEcCtD
Linagliptin—Rash—Midazolam—epilepsy syndrome	0.000248	0.00136	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000248	0.00136	CcSEcCtD
Linagliptin—Dermatitis—Midazolam—epilepsy syndrome	0.000248	0.00136	CcSEcCtD
Linagliptin—Urticaria—Carbamazepine—epilepsy syndrome	0.000247	0.00136	CcSEcCtD
Linagliptin—Headache—Midazolam—epilepsy syndrome	0.000246	0.00135	CcSEcCtD
Linagliptin—Diarrhoea—Diazepam—epilepsy syndrome	0.000246	0.00135	CcSEcCtD
Linagliptin—Rash—Levetiracetam—epilepsy syndrome	0.000245	0.00135	CcSEcCtD
Linagliptin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000245	0.00134	CcSEcCtD
Linagliptin—Headache—Levetiracetam—epilepsy syndrome	0.000243	0.00134	CcSEcCtD
Linagliptin—Malnutrition—Gabapentin—epilepsy syndrome	0.000243	0.00133	CcSEcCtD
Linagliptin—Angioedema—Pregabalin—epilepsy syndrome	0.000242	0.00133	CcSEcCtD
Linagliptin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000242	0.00133	CcSEcCtD
Linagliptin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00024	0.00132	CcSEcCtD
Linagliptin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000239	0.00131	CcSEcCtD
Linagliptin—Urticaria—Lamotrigine—epilepsy syndrome	0.000239	0.00131	CcSEcCtD
Linagliptin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000239	0.00131	CcSEcCtD
Linagliptin—Diarrhoea—Felbamate—epilepsy syndrome	0.000238	0.00131	CcSEcCtD
Linagliptin—Infection—Valproic Acid—epilepsy syndrome	0.000237	0.00131	CcSEcCtD
Linagliptin—Rash—Fosphenytoin—epilepsy syndrome	0.000236	0.0013	CcSEcCtD
Linagliptin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000236	0.0013	CcSEcCtD
Linagliptin—Back pain—Gabapentin—epilepsy syndrome	0.000235	0.00129	CcSEcCtD
Linagliptin—Headache—Fosphenytoin—epilepsy syndrome	0.000235	0.00129	CcSEcCtD
Linagliptin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000233	0.00128	CcSEcCtD
Linagliptin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000232	0.00128	CcSEcCtD
Linagliptin—Cough—Pregabalin—epilepsy syndrome	0.000231	0.00127	CcSEcCtD
Linagliptin—Rash—Vigabatrin—epilepsy syndrome	0.00023	0.00127	CcSEcCtD
Linagliptin—Dermatitis—Vigabatrin—epilepsy syndrome	0.00023	0.00126	CcSEcCtD
Linagliptin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000229	0.00126	CcSEcCtD
Linagliptin—Headache—Vigabatrin—epilepsy syndrome	0.000229	0.00126	CcSEcCtD
Linagliptin—Rash—Diazepam—epilepsy syndrome	0.000227	0.00125	CcSEcCtD
Linagliptin—Dermatitis—Diazepam—epilepsy syndrome	0.000226	0.00125	CcSEcCtD
Linagliptin—Myalgia—Pregabalin—epilepsy syndrome	0.000225	0.00124	CcSEcCtD
Linagliptin—Arthralgia—Pregabalin—epilepsy syndrome	0.000225	0.00124	CcSEcCtD
Linagliptin—Headache—Diazepam—epilepsy syndrome	0.000225	0.00124	CcSEcCtD
Linagliptin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000225	0.00123	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000224	0.00123	CcSEcCtD
Linagliptin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000223	0.00123	CcSEcCtD
Linagliptin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000222	0.00122	CcSEcCtD
Linagliptin—Angioedema—Gabapentin—epilepsy syndrome	0.000222	0.00122	CcSEcCtD
Linagliptin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000222	0.00122	CcSEcCtD
Linagliptin—Rash—Felbamate—epilepsy syndrome	0.000219	0.00121	CcSEcCtD
Linagliptin—Dermatitis—Felbamate—epilepsy syndrome	0.000219	0.00121	CcSEcCtD
Linagliptin—Headache—Felbamate—epilepsy syndrome	0.000218	0.0012	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000218	0.0012	CcSEcCtD
Linagliptin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000216	0.00119	CcSEcCtD
Linagliptin—Rash—Zonisamide—epilepsy syndrome	0.000215	0.00118	CcSEcCtD
Linagliptin—Infection—Pregabalin—epilepsy syndrome	0.000215	0.00118	CcSEcCtD
Linagliptin—Dermatitis—Zonisamide—epilepsy syndrome	0.000215	0.00118	CcSEcCtD
Linagliptin—Headache—Zonisamide—epilepsy syndrome	0.000213	0.00117	CcSEcCtD
Linagliptin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000213	0.00117	CcSEcCtD
Linagliptin—Immune system disorder—Topiramate—epilepsy syndrome	0.000212	0.00117	CcSEcCtD
Linagliptin—Cough—Gabapentin—epilepsy syndrome	0.000212	0.00116	CcSEcCtD
Linagliptin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000211	0.00116	CcSEcCtD
Linagliptin—Skin disorder—Pregabalin—epilepsy syndrome	0.00021	0.00115	CcSEcCtD
Linagliptin—Rash—Clonazepam—epilepsy syndrome	0.000207	0.00114	CcSEcCtD
Linagliptin—Dermatitis—Clonazepam—epilepsy syndrome	0.000207	0.00114	CcSEcCtD
Linagliptin—Myalgia—Gabapentin—epilepsy syndrome	0.000207	0.00114	CcSEcCtD
Linagliptin—Arthralgia—Gabapentin—epilepsy syndrome	0.000207	0.00114	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000206	0.00113	CcSEcCtD
Linagliptin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000206	0.00113	CcSEcCtD
Linagliptin—Headache—Clonazepam—epilepsy syndrome	0.000206	0.00113	CcSEcCtD
Linagliptin—Rash—Phenytoin—epilepsy syndrome	0.000206	0.00113	CcSEcCtD
Linagliptin—Dermatitis—Phenytoin—epilepsy syndrome	0.000205	0.00113	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000205	0.00113	CcSEcCtD
Linagliptin—Rash—Oxcarbazepine—epilepsy syndrome	0.000204	0.00112	CcSEcCtD
Linagliptin—Constipation—Valproic Acid—epilepsy syndrome	0.000204	0.00112	CcSEcCtD
Linagliptin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000204	0.00112	CcSEcCtD
Linagliptin—Headache—Phenytoin—epilepsy syndrome	0.000204	0.00112	CcSEcCtD
Linagliptin—Malnutrition—Topiramate—epilepsy syndrome	0.000204	0.00112	CcSEcCtD
Linagliptin—Headache—Oxcarbazepine—epilepsy syndrome	0.000203	0.00112	CcSEcCtD
Linagliptin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000198	0.00109	CcSEcCtD
Linagliptin—Back pain—Topiramate—epilepsy syndrome	0.000198	0.00109	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000197	0.00108	CcSEcCtD
Linagliptin—Infection—Gabapentin—epilepsy syndrome	0.000197	0.00108	CcSEcCtD
Linagliptin—Rash—Carbamazepine—epilepsy syndrome	0.000196	0.00108	CcSEcCtD
Linagliptin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000196	0.00108	CcSEcCtD
Linagliptin—Headache—Carbamazepine—epilepsy syndrome	0.000195	0.00107	CcSEcCtD
Linagliptin—Skin disorder—Gabapentin—epilepsy syndrome	0.000192	0.00106	CcSEcCtD
Linagliptin—Urticaria—Valproic Acid—epilepsy syndrome	0.00019	0.00104	CcSEcCtD
Linagliptin—Rash—Lamotrigine—epilepsy syndrome	0.00019	0.00104	CcSEcCtD
Linagliptin—Dermatitis—Lamotrigine—epilepsy syndrome	0.000189	0.00104	CcSEcCtD
Linagliptin—Headache—Lamotrigine—epilepsy syndrome	0.000188	0.00104	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000187	0.00103	CcSEcCtD
Linagliptin—Constipation—Pregabalin—epilepsy syndrome	0.000185	0.00102	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000181	0.000992	CcSEcCtD
Linagliptin—Cough—Topiramate—epilepsy syndrome	0.000178	0.00098	CcSEcCtD
Linagliptin—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000176	0.000968	CcSEcCtD
Linagliptin—Arthralgia—Topiramate—epilepsy syndrome	0.000174	0.000956	CcSEcCtD
Linagliptin—Myalgia—Topiramate—epilepsy syndrome	0.000174	0.000956	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000173	0.000949	CcSEcCtD
Linagliptin—Urticaria—Pregabalin—epilepsy syndrome	0.000172	0.000944	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000171	0.00094	CcSEcCtD
Linagliptin—Constipation—Gabapentin—epilepsy syndrome	0.000169	0.000932	CcSEcCtD
Linagliptin—Infection—Topiramate—epilepsy syndrome	0.000166	0.00091	CcSEcCtD
Linagliptin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000164	0.000899	CcSEcCtD
Linagliptin—Skin disorder—Topiramate—epilepsy syndrome	0.000162	0.00089	CcSEcCtD
Linagliptin—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000159	0.000875	CcSEcCtD
Linagliptin—Urticaria—Gabapentin—epilepsy syndrome	0.000157	0.000865	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000152	0.000835	CcSEcCtD
Linagliptin—Rash—Valproic Acid—epilepsy syndrome	0.000151	0.000829	CcSEcCtD
Linagliptin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000151	0.000828	CcSEcCtD
Linagliptin—Headache—Valproic Acid—epilepsy syndrome	0.00015	0.000823	CcSEcCtD
Linagliptin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000148	0.000813	CcSEcCtD
Linagliptin—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000146	0.000803	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000144	0.000791	CcSEcCtD
Linagliptin—Constipation—Topiramate—epilepsy syndrome	0.000143	0.000784	CcSEcCtD
Linagliptin—Rash—Pregabalin—epilepsy syndrome	0.000136	0.000749	CcSEcCtD
Linagliptin—Dermatitis—Pregabalin—epilepsy syndrome	0.000136	0.000748	CcSEcCtD
Linagliptin—Diarrhoea—Gabapentin—epilepsy syndrome	0.000136	0.000745	CcSEcCtD
Linagliptin—Headache—Pregabalin—epilepsy syndrome	0.000135	0.000744	CcSEcCtD
Linagliptin—Urticaria—Topiramate—epilepsy syndrome	0.000132	0.000728	CcSEcCtD
Linagliptin—Rash—Gabapentin—epilepsy syndrome	0.000125	0.000687	CcSEcCtD
Linagliptin—Dermatitis—Gabapentin—epilepsy syndrome	0.000125	0.000686	CcSEcCtD
Linagliptin—Headache—Gabapentin—epilepsy syndrome	0.000124	0.000682	CcSEcCtD
Linagliptin—Hypersensitivity—Topiramate—epilepsy syndrome	0.000123	0.000675	CcSEcCtD
Linagliptin—Diarrhoea—Topiramate—epilepsy syndrome	0.000114	0.000627	CcSEcCtD
Linagliptin—Rash—Topiramate—epilepsy syndrome	0.000105	0.000578	CcSEcCtD
Linagliptin—Dermatitis—Topiramate—epilepsy syndrome	0.000105	0.000577	CcSEcCtD
Linagliptin—Headache—Topiramate—epilepsy syndrome	0.000104	0.000574	CcSEcCtD
Linagliptin—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000103	0.0119	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000102	0.0117	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000102	0.0117	CbGpPWpGaD
Linagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000101	0.0116	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	9.69e-05	0.0112	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCC2—epilepsy syndrome	9.26e-05	0.0107	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—NEU1—epilepsy syndrome	9.19e-05	0.0106	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—EIF2AK3—epilepsy syndrome	9.19e-05	0.0106	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	8.93e-05	0.0103	CbGpPWpGaD
Linagliptin—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	8.55e-05	0.00986	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PIGA—epilepsy syndrome	8.54e-05	0.00985	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—TPP1—epilepsy syndrome	8.54e-05	0.00985	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	8.43e-05	0.00972	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NT5E—epilepsy syndrome	8.22e-05	0.00948	CbGpPWpGaD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	8.11e-05	0.00935	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—EIF2B5—epilepsy syndrome	8.03e-05	0.00926	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ADD1—epilepsy syndrome	7.61e-05	0.00878	CbGpPWpGaD
Linagliptin—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	7.56e-05	0.00872	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	7.27e-05	0.00839	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ST3GAL3—epilepsy syndrome	7.11e-05	0.0082	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ST3GAL5—epilepsy syndrome	6.83e-05	0.00788	CbGpPWpGaD
Linagliptin—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	6.78e-05	0.00782	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	6.52e-05	0.00752	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ATP6AP2—epilepsy syndrome	6.47e-05	0.00747	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	6.27e-05	0.00723	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—epilepsy syndrome	6.15e-05	0.00709	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—GDNF—epilepsy syndrome	6.05e-05	0.00698	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	5.97e-05	0.00688	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	5.51e-05	0.00636	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	5.5e-05	0.00635	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	5.48e-05	0.00632	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	5.28e-05	0.00608	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	5.19e-05	0.00599	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	5.13e-05	0.00592	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—epilepsy syndrome	4.85e-05	0.00559	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—EIF2S1—epilepsy syndrome	4.37e-05	0.00504	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACTB—epilepsy syndrome	4.32e-05	0.00498	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—EPO—epilepsy syndrome	4.16e-05	0.00479	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	4.04e-05	0.00466	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	3.94e-05	0.00455	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—epilepsy syndrome	3.87e-05	0.00447	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—epilepsy syndrome	3.83e-05	0.00442	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—BCHE—epilepsy syndrome	3.72e-05	0.00429	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	3.71e-05	0.00427	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	3.35e-05	0.00387	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.32e-05	0.00383	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	3.32e-05	0.00383	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PLAUR—epilepsy syndrome	3.23e-05	0.00373	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.17e-05	0.00365	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.16e-05	0.00365	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	3.15e-05	0.00363	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.14e-05	0.00362	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.12e-05	0.0036	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.1e-05	0.00357	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.08e-05	0.00355	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.82e-05	0.00325	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.78e-05	0.00321	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	2.73e-05	0.00314	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	2.73e-05	0.00314	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.56e-05	0.00295	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.55e-05	0.00294	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.53e-05	0.00292	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	2.43e-05	0.0028	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	2.43e-05	0.0028	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	2.43e-05	0.0028	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	2.39e-05	0.00275	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	2.39e-05	0.00275	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—AGT—epilepsy syndrome	2.28e-05	0.00263	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.28e-05	0.00263	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	2.25e-05	0.0026	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	2.22e-05	0.00256	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	2.08e-05	0.0024	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	1.94e-05	0.00224	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—POMC—epilepsy syndrome	1.92e-05	0.00222	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CCL2—epilepsy syndrome	1.88e-05	0.00217	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	1.84e-05	0.00212	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	1.84e-05	0.00212	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	1.84e-05	0.00212	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	1.76e-05	0.00203	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	1.76e-05	0.00203	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	1.76e-05	0.00203	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	1.63e-05	0.00187	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA13—epilepsy syndrome	1.5e-05	0.00173	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	1.49e-05	0.00172	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	1.43e-05	0.00165	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	1.4e-05	0.00161	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	1.4e-05	0.00161	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.38e-05	0.00159	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.35e-05	0.00156	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.34e-05	0.00155	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	1.33e-05	0.00154	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.33e-05	0.00154	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.33e-05	0.00153	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	1.33e-05	0.00153	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.33e-05	0.00153	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.31e-05	0.00152	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.31e-05	0.00151	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	1.3e-05	0.0015	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.28e-05	0.00147	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.28e-05	0.00147	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.28e-05	0.00147	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.28e-05	0.00147	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.21e-05	0.0014	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.2e-05	0.00138	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.19e-05	0.00137	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADK—epilepsy syndrome	1.14e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.13e-05	0.00131	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.13e-05	0.0013	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.12e-05	0.00129	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.12e-05	0.00129	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.08e-05	0.00125	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.04e-05	0.0012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.04e-05	0.0012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.04e-05	0.0012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.04e-05	0.0012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.04e-05	0.0012	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.01e-05	0.00116	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.01e-05	0.00116	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	9.94e-06	0.00115	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	9.68e-06	0.00112	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—QDPR—epilepsy syndrome	9.67e-06	0.00112	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA4—epilepsy syndrome	9.67e-06	0.00112	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	9.67e-06	0.00112	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA13—epilepsy syndrome	9.25e-06	0.00107	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—COX3—epilepsy syndrome	9.1e-06	0.00105	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	8.99e-06	0.00104	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	8.68e-06	0.001	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	8.62e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—KCNB1—epilepsy syndrome	8.62e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	8.62e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PFKL—epilepsy syndrome	8.62e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	8.62e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	8.32e-06	0.000959	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.22e-06	0.000948	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.01e-06	0.000924	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NEU1—epilepsy syndrome	7.89e-06	0.000909	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UPB1—epilepsy syndrome	7.89e-06	0.000909	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ATIC—epilepsy syndrome	7.89e-06	0.000909	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	7.84e-06	0.000904	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	7.59e-06	0.000875	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	7.45e-06	0.000859	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	7.33e-06	0.000845	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GBE1—epilepsy syndrome	7.33e-06	0.000845	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	7.07e-06	0.000816	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADK—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PDXK—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CERS1—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FAR1—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	7.01e-06	0.000808	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ASAH1—epilepsy syndrome	6.89e-06	0.000795	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.81e-06	0.000786	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—STXBP1—epilepsy syndrome	6.71e-06	0.000773	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	6.57e-06	0.000757	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NT5E—epilepsy syndrome	6.53e-06	0.000754	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALAD—epilepsy syndrome	6.53e-06	0.000754	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.5e-06	0.00075	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.41e-06	0.000739	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.41e-06	0.000739	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.41e-06	0.000739	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.41e-06	0.000739	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	6.38e-06	0.000735	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	6.23e-06	0.000719	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	6.23e-06	0.000719	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	6.1e-06	0.000703	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADSL—epilepsy syndrome	5.98e-06	0.000689	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.96e-06	0.000687	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.96e-06	0.000687	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.94e-06	0.000685	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GLUL—epilepsy syndrome	5.86e-06	0.000676	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	5.75e-06	0.000663	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	5.72e-06	0.00066	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.6e-06	0.000646	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	5.57e-06	0.000643	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	5.38e-06	0.000621	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.35e-06	0.000617	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.31e-06	0.000613	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.31e-06	0.000613	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.31e-06	0.000613	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.31e-06	0.000613	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.31e-06	0.000613	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.3e-06	0.000611	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.22e-06	0.000602	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.86e-06	0.00056	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.86e-06	0.00056	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.86e-06	0.00056	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.78e-06	0.000551	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.72e-06	0.000545	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.72e-06	0.000545	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.68e-06	0.000539	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.52e-06	0.000521	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.52e-06	0.000521	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.25e-06	0.00049	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.13e-06	0.000476	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.03e-06	0.000464	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.03e-06	0.000464	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.85e-06	0.000444	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.84e-06	0.000443	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.84e-06	0.000443	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.76e-06	0.000433	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.75e-06	0.000433	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.73e-06	0.00043	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.68e-06	0.000425	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.61e-06	0.000416	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.56e-06	0.00041	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.54e-06	0.000409	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.37e-06	0.000388	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.32e-06	0.000382	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.22e-06	0.000371	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.21e-06	0.00037	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.2e-06	0.00037	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.19e-06	0.000368	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.04e-06	0.000351	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.01e-06	0.000347	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TH—epilepsy syndrome	3e-06	0.000346	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.91e-06	0.000336	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.91e-06	0.000336	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.5e-06	0.000289	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAT—epilepsy syndrome	2.47e-06	0.000285	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.37e-06	0.000274	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.31e-06	0.000267	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.3e-06	0.000265	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.23e-06	0.000258	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.07e-06	0.000239	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.97e-06	0.000228	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.97e-06	0.000227	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.96e-06	0.000226	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.92e-06	0.000221	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.88e-06	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.86e-06	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.85e-06	0.000213	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.65e-06	0.00019	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.54e-06	0.000178	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.52e-06	0.000176	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.5e-06	0.000173	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.48e-06	0.000171	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.38e-06	0.000159	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	0.000152	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.21e-06	0.000139	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.18e-06	0.000136	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.02e-06	0.000117	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.26e-07	0.000107	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.1e-07	9.35e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—epilepsy syndrome	6.61e-07	7.62e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.07e-07	4.7e-05	CbGpPWpGaD
